Skip to main content

Perspectives

“Hoodoo” You Think Will Change?

David B. Nash, MD, MBA

David B. Nash, MD, MBA

"The Dirty Dozen"

David B. Nash, MD, MBA

David B. Nash, MD, MBA

David B. Nash, MD, MBA

David B. Nash, MD, MBA

Can We Make Medicines Affordable?

David B. Nash, MD, MBA

David B. Nash, MD, MBA

Is Adequate Nutrition Cost-Effective?

David B. Nash, MD, MBA

David B. Nash, MD, MBA

David B. Nash, MD, MBA

David B. Nash, MD, MBA

A Nurse Navigator’s Perspective on CDK4/6 Inhibitors

Sharon S. Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN

A Payer’s Perspective on CDK4/6 Inhibitors

Kenneth L. Schaecher, MD, FACP, CPC

A Pharmacist’s Perspective on CDK4/6 Inhibitors

Robert C. Wolf, PharmD

David B. Nash, MD, MBA

David B. Nash, MD, MBA

Page 5 of 18
Results 41 - 50 of 173